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Introduction: Inclusions of ectopic breast tissue in axillary lymph nodes are reported very infrequently and typically
are only identified microscopically as an incidental finding. Furthermore the development of a benign proliferative
lesion in the form of an intraductal papilloma from intranodal ectopic breast tissue is an extremely rare phenomenon
with only three previous cases reported. This report describes an unusual and rare case of an intraductal papilloma
arising in an axillary lymph node of a patient known to have the human immunodeficiency virus.
Case presentation: A 40-year-old Black African woman underwent excision of an enlarged palpable axillary lymph
node. In the preceding 7 years she had received at least six separate surgical excisions to her ipsilateral breast for
papillomatosis. The last surgical intervention was performed 1 year prior to presentation with an enlarged axillary lymph
node. Histological examination of her axillary lymph node revealed a papillomatous proliferative epithelial lesion within
an apparent encompassing duct, resembling a mammary intraductal papilloma. In the surrounding lymphoid tissue
small groups of duct-like structures were additionally noted. Immunostaining with a panel of myoepithelial markers in
conjunction with oestrogen receptor produced a mixed heterogeneous staining pattern in both the papillomatous
lesion and the peripheral duct-like structures. This confirmed the diagnosis of a benign intraductal papilloma within an
axillary lymph node, considered to have arisen from ectopic breast tissue.
Conclusions: This case demonstrates that intranodal ectopic breast tissue has the potential to undergo benign
proliferative change albeit extremely rarely. Therefore this possibility must be considered to ensure the correct
diagnosis is made. In addition, to the best of our knowledge, this is the first case report which has described recurrent
intraductal papillomas and the subsequent development of an intraductal papilloma within an ipsilateral axillary lymph
node, in a patient who is human immunodeficiency virus positive. There is minimal literature investigating the specific
types of breast pathologies experienced by patients infected with human immunodeficiency virus and it remains
unexplored as to whether human immunodeficiency virus may lead to proliferative papillomatous epithelial changes.
This report considers the role of the human papillomavirus and recommends that further investigatory studies
are required.
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Intraductal papillomas (IDPs) are discrete benign tumours
arising in mammary ducts. They comprise a proliferation
of epithelial and myoepithelial cells which are supported
by fibrovascular cores, producing a characteristic arbor-
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is an extremely rare phenomenon. A review of the lit-
erature has revealed only three reports of an IDP arising
within an axillary lymph node [4-6]. In this report we
describe a further unusual case of an IDP arising in an
axillary lymph node of a patient known to have the hu-
man immunodeficiency virus (HIV) and a previous his-
tory of recurrent IDPs of the ipsilateral breast.
Case presentation
Our patient was a 40-year-old Black African woman with
a medical history of HIV infection and mild depression.
She was a non-smoker and had no known drug allergies.
Her medication included venlafaxine, and reverse tran-
scriptase inhibitors efavirenz (non-nucleoside) and lami-
vudine (nucleoside). She had originally attended 4 years
previously with left nipple discharge associated with pain
and discomfort of her left breast. Ultrasound imaging with
core biopsies revealed multiple benign IDPs in her left
breast and she underwent a Hadfield’s procedure (radical
subareolar duct excision). Another Hadfield’s procedure
was performed in the following year (2007) after recur-
rence of the benign IDPs. In 2010 she underwent a left
subcutaneous mastectomy with implant reconstruction
following development of a further IDP in her left breast.
This form of surgical treatment was decided most ap-
propriate due to the extent of the IDP, difficulty of
radiological follow-up and to exclude atypia and risk of
subsequent malignancy. In the mastectomy specimen a
single IDP was present measuring approximately 38×22mm
in maximum dimension. The IDP contained several suspi-
cious foci of solid atypical proliferations, which after immu-
nohistochemical staining were regarded as atypical ductal
hyperplasia. The degree of atypia was not considered to
amount to ductal carcinoma in situ (DCIS) and there was
no evidence of invasive neoplasia. No axillary lymphaden-
opathy was noted at the time of the mastectomy. In situ
hybridisation for the detection of human papillomavirus
(HPV) was performed on two separate IDPs (in 2008 and
the IDP in the mastectomy specimen in 2010). In both
cases no HPV was detected with the probe set used (HPV
1, 2, 6, 11, 16, 18, 31 and 33). During follow up, 2 years
after her left mastectomy (in 2012), she reported a small
lump in her left breast. Ultrasound imaging revealed a
new 9mm well-defined hypoechoic mass. This was shown
on core biopsy to be a further IDP. Diagnostic excision of
the lesion confirmed a benign IDP with hyperplasia, apo-
crine metaplasia and no evidence of atypia.
In 2013 she developed an enlarged palpable mass in
her left axilla.
Diagnostic focus and assessment
On ultrasound imaging the axillary mass corresponded
to an abnormally enlarged lymph node with eccentriccortical thickening and loss of medullary fat (Figure 1A).
No changes or abnormalities were detected in her left
breast. Left axillary ultrasound-guided core biopsies of the
lymph node revealed part of an IDP. As a result of this
extremely unusual finding a diagnostic excision of the
enlarged left axillary lymph node was performed. The
lymph node measured 20mm in maximum dimension.
The histology of the lymph node showed a reasonably
well-circumscribed papillomatous proliferative epithelial
lesion within an apparent encompassing duct. The lesion
was confined to the node and comprised prominent
tightly packed papillary fronds lined by a bilayer of luminal
epithelial cells and an outer layer of basal cells supported
by fibrovascular cores (Figures 1B and 1C); identical to an
IDP of the breast. Cholesterol crystals, dense collections
of macrophages and reactive stromatolites were also noted
in part, signifying a long standing lesion and the latter in-
dicative of previous core biopsy. No necrosis or significant
atypia was evident and few mitoses were identified. At the
periphery, benign lymphoid tissue was seen confirming
the intranodal location of the lesion. In this surrounding
lymphoid tissue small groups of duct-like structures were
additionally noted (Figure 1D). In view of the curious
finding of an IDP within an axillary lymph node immu-
nohistochemical staining was performed for confirmatory
characterisation of the lesion and exclusion of malignancy.
The lesion and encompassing duct demonstrated mixed
cytokeratin (CK) 5 and 14, p63 and smooth muscle
myosin positivity (Figures 1E-G) with heterogeneous
oestrogen receptor (ER) expression, indicating a benign le-
sion. A similar staining pattern was also displayed in the
duct-like epithelial structures thereby determining their
origin as breast. The histological appearances and immu-
nohistochemical staining profile therefore substantiated a
benign IDP within her left axillary lymph node, which was
considered to have arisen from EBT.
She experienced an uneventful postoperative period
and remains well at follow up appointments. Her recent
annual contralateral mammogram (performed 1-month
post-lymph node excision) revealed no significant interval
change in her right breast when compared with previous
mammograms, and no palpable axillary lymph nodes were
identified.
Conclusions
It is estimated that EBT is found in approximately 1% of
the population [7]; however, its presence in axillary lymph
nodes is uncommon and when it does occur it is frequently
an incidental microscopic finding [2-4]. The aetiology of
intranodal EBT remains unclear. It has been postulated
that it may result from embryological maldevelopment
leading to entrapment of mammary epithelial cells within
nodal tissue or as a consequence of cell embolism follow-
ing breast surgery [4,8-10]. Table 1 summarises the three
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Figure 1 Ultrasound imaging and photomicroscopy of the axillary intraductal papilloma. A Ultrasound imaging of the axillary lymph node.
B and C: Histological appearance of the intraductal papilloma in the left axillary lymph node, magnification ×10. D: Illustration of duct-like epithelial
structures in the adjacent lymphoid tissue considered to represent ectopic breast tissue, magnification ×20. E-G: Immunohistochemical staining profile
of the intraductal papilloma with mixed positivity to cytokeratin 5 (E), smooth muscle myosin (F) and p63 (G), magnification ×20.










Size (mm) Suspected aetiopathogenesis
Ichihara et al.
[4] (2008)
47 5 ipsilateral IDPs in
the preceding 5 years
Incidental discovery during
sentinel lymph node biopsy
6 Postulation of mammary epithelial cell dissemination
following multiple surgical manipulations to ipsilateral
breast OR from EBP
Dzodic et al.
[5] (2010)




11 Favoured evolvement from intranodal EBT as duct-like
structures identified in the background lymphoid tissue
McDiwitt et al.
[6] (1968)
Not stated Not stated Not stated Not stated Description of case only
Current case (2014) 40 >6 ipsilateral IDPs in
the preceding 7 years
Presentation as palpable
axillary lymph node
20 Favoured evolvement from intranodal EBT as duct-like
structures identified in the background lymphoid tissue
Abbreviations: EBT, ectopic breast tissue; IDP, intraductal papilloma.
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lymph node and our case.
The behaviour and evolution of EBT is unpredictable
and particularly unexplored in relation to axillary lymph
nodes owing to its rarity. Several studies have demon-
strated EBT to exhibit squamous and apocrine metaplasia,
cystic change and epithelial hyperplasia [3,4,8-10]. These
findings would suggest that EBT is susceptible to similar
hormonal influences and changes as native mammary
tissue. Accordingly, it is feasible for benign proliferative
lesions such as IDPs to develop from such EBT, albeit
exceptionally rare within the axillary lymph nodes. It is
therefore also conceivable that malignant transform-
ation is possible. This is incredibly rare with only two
case reports identified in the literature [11,12]. Jaffer
et al. (2008) in their case report described transform-
ation of an IDP within an axillary lymph node into an
intraductal carcinoma. Their patient had a previous his-
tory of an ipsilateral lumpectomy for an IDP which dis-
played atypical ductal hyperplasia and focal DCIS [11].
The other case report documented a case of papillary
carcinoma arising in an axillary lymph node also consid-
ered to have originated from EBT [12]. Therefore an ex-
tremely important ramification of intranodal EBTs is to
ensure that they are not misinterpreted as either meta-
static carcinoma or a primary malignancy. This may be
of particular diagnostic difficulty if there has been prolifer-
ative change. Nevertheless pathologists and clinicians must
be mindful of the possible occurrence of EBT in axillary
lymph nodes and the very infrequent proliferative changes
that it may display. In the current case, cystic change asso-
ciated with cholesterol deposition indicated a long stand-
ing lesion. Focal disruption to the IDP within the axillary
lymph node was also noted with small epithelial islands
seen to extend beyond the encompassing duct. This was
however found in association with inflammation and re-
active changes consistent with a previous core biopsy site.
It was therefore considered artefactual in nature represent-
ing epithelial displacement within. In addition, the recog-
nition and demonstration of myoepithelial cells and the
heterogeneous ER and CK5 immunohistochemical stain-
ing confirmed the lesion as benign.
In our case report the patient was known to be HIV
positive and had undergone to this date at least six separ-
ate surgical excisions to her left breast for papillomatosis.
This included two Hadfield’s and an eventual left mastec-
tomy and breast reconstruction. There is minimal litera-
ture investigating the specific types of breast pathologies
experienced by patients infected with HIV. To the best of
our knowledge this is the first case report which has de-
scribed recurrent IDPs and the subsequent development
of an IDP within an ipsilateral axillary lymph node, in a
patient who is HIV positive. It is contemplated that HIV
may affect the glandular elements of breast tissue inseropositive patients [13], although it remains unexplored
as to whether this may lead to proliferative papillomatous
epithelial changes. It has been demonstrated that in pa-
tients with HIV-1 disease, such as in our patient, there is
greater infection with HPV in multiple locations including
the nipple [14]. HPV is widely recognised as the cause
of papillomas in multiple sites and therefore could have
a role to play in the aetiopathogenesis of IDPs [15]. Cur-
rently though there is limited information on this rela-
tionship and certainly in our case no HPV was detected.
Further studies investigating the potential role of HPV
in IDPs and the effects of HIV on the breast and EBT
are required.
Consent
Written informed consent was obtained from the patient
for publication of this case report and accompanying im-
ages. A copy of the written consent is available for review
by the Editor-in-Chief of this journal.
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